(Q37154123)

18 August 2017

1 reference

title

Managing acute chest syndrome of sickle cell disease in an African setting (English)

1 reference

18 August 2017

0 references

1 reference

A E Fawibe

1

1 reference

18 August 2017

publication date

2 May 2008

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

18 August 2017

published in

1 reference

18 August 2017

volume

102

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

526-531

1 reference

Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

"Acute chest syndrome" in adults with sickle cell anemia. Microbiology, treatment, and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Steroid treatment in children with sickle-cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Alveolar-arterial oxygen gradient in acute chest syndrome of sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Acute chest syndrome and sickle cell disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Pulmonary edema. Complication in the management of sickle cell pain crisis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Acute sickle cell syndromes in Nigerian adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

In vitro effects of NIPRISAN (Nix-0699): a naturally occurring, potent antisickling agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Asthma in children with sickle cell disease and its association with acute chest syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Red cell exchange in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Hydroxyurea reacts with heme proteins to generate nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Red cell exchange in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

7 January 2021

Pulmonary complications

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

The diagnosis of pulmonary thromboembolism in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

Bone marrow transplantation for sickle cell disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

NHLBI Workshop Summary. Pathogenesis of lung disease in sickle hemoglobinopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.018

10.1016/J.TRSTMH.2008.03.018

7 January 2021

Identifiers

DOI

1 reference

18 August 2017

1 reference